Log on / register
Feedback | Support | My details
The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.
Fassett RG, Ball MJ, Robertson IK, Geraghty DP, Coombes JS
BMC Nephrol 2008, 9:4
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.